Paul F. McKenzie

2017

In 2017, Paul F. McKenzie earned a total compensation of $5M as Executive Vice President, Pharmaceutical Operations & Technology at Biogen.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$2,471
Non-Equity Incentive Plan$796,648
Salary$600,433
Stock Awards$3,514,451
Other$101,254
Total$5,015,257

McKenzie received $3.5M in stock awards, accounting for 70% of the total pay in 2017.

McKenzie also received $2.5K of change in pension value and nonqualified deferred compensation earnings, $796.6K in non-equity incentive plan, $600.4K in salary and $101.3K in other compensation.

Rankings

In 2017, Paul F. McKenzie's compensation ranked 1,887th out of 14,666 executives tracked by ExecPay. In other words, McKenzie earned more than 87.1% of executives.

ClassificationRankingPercentile
All
1,887
out of 14,666
87th
Division
Manufacturing
634
out of 5,770
89th
Major group
Chemicals And Allied Products
168
out of 2,074
92nd
Industry group
Drugs
123
out of 1,730
93rd
Industry
Biological Products, Except Diagnostic Substances
27
out of 316
92nd
Source: SEC filing on April 27, 2018.

McKenzie's colleagues

We found eight more compensation records of executives who worked with Paul F. McKenzie at Biogen in 2017.

2017

Michel Vounatsos

Biogen

Chief Executive Officer

2017

George Scangos

Biogen

Chief Executive Officer

2017

Kenneth DiPietro

Biogen

Former Executive Vice President, Human Resources

2017

Michael Ehlers

Biogen

Executive Vice President, Research & Development

2017

Susan Alexander

Biogen

Chief Legal Officer

2017

Paul Clancy

Biogen

Chief Financial Officer

2017

Gregory Covino

Biogen

Chief Accounting Officer

2017

Jeffrey Capello

Biogen

Chief Financial Officer

News

You may also like